COLUMBIA, Md., Aug. 23 Martek Biosciences, a DHAomega-3 market leader, announced today that the Ministry of Health in Chinahas authorized the use of the company's life'sDHA(TM) as a novel foodingredient. This new designation will permit the immediate use of Martek'slife'sDHA(TM) in foods, beverages and supplements in China for persons olderthan twelve months. Since 2001, Martek's life'sDHA(TM) and life'sARA(TM)(arachidonic acid), an omega-6 fatty acid, have been used in infant formulathroughout China.
DHA (docosahexaenoic acid) omega-3 is a long-chain omega-3 fatty acid thatserves as a primary building block for the brain and the eyes and supportsbrain, eye and cardiovascular health throughout life. There is a large andgrowing body of scientific evidence demonstrating that people of all ages,from infants to aging adults, benefit from an adequate supply of DHA omega-3in their diets. Scientific reviews have noted the importance of DHA omega-3 inproper brain and eye function, and there are studies currently underway toinvestigate its role in decreasing the prevalence of certain neurologicaldisorders.
Martek's life'sDHA(TM) is unique in the market because it is derived froma sustainable and vegetarian source. Made from microalgae under tightlycontrolled manufacturing conditions, life'sDHA(TM) is free of oceaniccontaminants that may be present in certain fish or fish oils. Microalgae arethe only vegetarian source of DHA omega-3, the key omega-3 for brain and eyedevelopment and function.
Martek opened a representative office in Shanghai earlier this year.Qingdao Samuels Industrial and Commercial Company, Ltd. has been appointed asMartek's distributor for life'sDHA(TM) in China. Samuels will be responsiblefor the selling and distribution activities surrounding life'sDHA(TM) in food(excluding infant formula), beverage and supplement applications in China,Hong Kong and Macao. Additional details and contact information for Samuelsmay be obtained at http://www.samuels.cn or from Martek.
This initial approval by the Ministry of Health is part of the regulatoryprocess applicable to Chinese novel foods and continues through August 5,2009. Martek may then apply for a final novel food certificate.
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in theinnovation and development of DHA omega-3 products that promote health andwellness through every stage of life. The company produces life'sDHA(TM), asustainable and vegetarian source of the omega-3 fatty acid DHA(docosahexaenoic acid), for use in foods, beverages, infant formula, andsupplements. The company also produces life'sARA(TM) (arachidonic acid), anomega-6 fatty acid, from a sustainable, vegetarian source, for use in infantformula. For more information on Martek Biosciences Corporation, visithttp://www.martek.com.
Sections of this release contain forward-looking statements. Thesestatements are based upon numerous assumptions which Martek cannot control andinvolve risks and uncertainties that could cause actual results to differ.These statements should be understood in light of the risk factors set forthin the company's filings with the Securities and Exchange Commission,including, but not limited to, the company's Form 10-K for the fiscal yearended October 31, 2006 and other filed reports on Form 10-K, Form 10-K/A, Form10-Q and Form 8-K.Contact: Kyle Stults Investor Relations (410)740-0081 [email protected]
SOURCE Martek Biosciences Corporation